|
|
                          |
 |
HIV Drug Resistance Mutations The HIV Drug Resistance Mutations Figures and User Notes are regularly revised and disseminated by the IAS–USA Drug Resistance Mutations Group, an independent volunteer panel of experts focused on identifying key HIV-1 drug resistance mutations. The group strives to provide current, accurate, and unbiased information on these mutations for HIV practitioners. The mutations figures and accompanying text are published in Topics in HIV Medicine. The most recent revision is available in the April/May 2008 issue. The IAS–USA has recently compiled a list of resources related to HIV drug resistant mutations. This list will be expanded in the upcoming months. The Mutations Figures and User Notes are available as downloadable PowerPoint file. The figures will soon be available in pocket-sized folding cards, available in both Spanish and English. To request folding cards, complete the card request form and return via fax at (415) 544-9401, or mail to the address shown on the card. You may also send an e-mail to resistance2008 “at” iasusa.org, or call the IAS-USA at (415) 544-9400. Request to Reprint Figures The Drug Resistance Mutations Group welcomes interest in the mutations figures as an educational resource for practitioners and encourages availability of the material for as broad an audience as possible. If you wish to reprint the mutations figures, we require that permission be obtained. Please send your request to the IAS-USA via e-mail at resistance2008 “at” iasusa.org or by fax at (415) 544-9401. Requests to reprint the material should include the name of the publisher or sponsor, the name or a description of the publication in which you wish to reprint the material, the funding organization(s), if applicable, and the intended audience of the publication. If possible, please include a copy of the proposed reproduction with your request. Please note that permission will be granted only for requests to reprint the most current version of the mutations figures as it is posted on the IAS–USA Website. Because scientific understanding of HIV drug resistance is evolving quickly and the goal of the Drug Resistance Mutations Group is to maintain the most up-to-date compilation of mutations for HIV clinicians and researchers, the publication of out-of-date figures is counterproductive. If you have any questions regarding reprints or permissions for use of the mutations figures, please send an e-mail to resistance2008 “at” iasusa.org. Suggestions The Drug Resistance Mutations Group reviews new data as they emerge and welcomes comments and evidence-based suggestions for revisions (be sure to provide any relevant reference citations). Please submit comments and suggestions to resistance2008 “at” iasusa.org.
|
|